Anti-PD-1 antibody SHR-1210 plus apatinib for metastatic colorectal cancer: a prospective, single-arm, open-label, phase II trial

Ren, C; Mai, ZJ; Jin, Y; He, MM; Wang, ZQ; Luo, HY; Zhang, DS; Wu, CY; Wang, F; Xu, RH

AMERICAN JOURNAL OF CANCER RESEARCH, 2020; 10 (9): 2946

Abstract

In the REGONIVO study, regorafenib combined with nivolumab was effective in the treatment of microsatellite stable (MSS) metastatic colorectal cancer ......

Full Text Link